| Literature DB >> 35990241 |
Xuenan Pang1, Yanfei Jin1, Honghong Wang1.
Abstract
Objective: As patients and family caregivers are increasingly viewed as a dyadic whole, growing studies have emerged that identify ways to improve the two parties' emotional distress. However, the specific effectiveness, quality, and optimal intervention details of these studies are unclear. Our objective is to synthesize the effectiveness of existing dyadic interventions for improving the psychological distress of cancer patient-caregiver dyads and identify potential moderators that influence intervention effectiveness.Entities:
Keywords: Cancer; Dyads; Family caregivers; Meta-aanalysis; Patients; Psychological distress; Systematic review
Year: 2022 PMID: 35990241 PMCID: PMC9382138 DOI: 10.1016/j.apjon.2022.100104
Source DB: PubMed Journal: Asia Pac J Oncol Nurs ISSN: 2347-5625
Fig. 1Flow diagram depicting the literature search in accordance with PRISMA 2020 guidelines.
Study characteristics of the systematic review (k = 28).
| Item | ||
|---|---|---|
| Breast | 4 (14) | |
| Lung | 4 (14) | |
| Prostate | 6 (21) | |
| Myeloma other | 2 (7) | |
| Gastrointestinal | 2 (7) | |
| Head and neck | 2 (7) | |
| Mixed | 8 (30) | |
| Spouse only | 13 (46) | |
| Family member or other | 15 (54) | |
| Patient | 58.26 | |
| Caregiver | 55.35 | |
| 171 | ||
| 41.18% | ||
| 68.77% | ||
| Psychologist | 5 (18) | |
| Nurse | 7 (25) | |
| Psychologist and nurse | 2 (7) | |
| Therapist | 8 (29) | |
| Online resources | 2 (7) | |
| Other | 4 (14) | |
| Usual care | 18 (64) | |
| Wait-list control | 3 (11) | |
| Other intervention | 7 (25) | |
| 0 | 13 (46) | |
| 1 | 4 (14) | |
| 2 | 5 (18) | |
| 3 | 3 (11) | |
| 4 | 3 (11) | |
| 4 (14) | ||
| 2 (7) | ||
| 11 (39) | ||
| 1 (4) | ||
k, number of studies.
Systematic review of randomized interventions involving psychological distress among cancer dyads (k = 28).
| Author | Sample demographics and follow-up | Therapy type, intervention delivery/dosage | Intervention and control group | Assessment tool | Main findings |
|---|---|---|---|---|---|
| Gremore et al (2021), | CES-D, | Patients' and partners' anxiety and depression effect sizes ranged from small to large, but partners' results changed less. | |||
| Steel | CES-D, | Experimental group demonstrated clinical improvement in survival rate, but not to a statistically significant degree. | |||
| Tiete | HADS | Intervention had no significant effect on emotional distress. | |||
| Wolff | PHQ-2, | Anxiety was more severe between baseline and nine months among control caregivers (18.2% vs. 12.7%). | |||
| Milbury | CES-D, | CBM couples experienced significant reduction in depressive symptoms compared to TAU, and it had a moderate effect size on depressive symptoms compared to SE. Patients with CBM benefited more than those in the SE group. | |||
| Lau | Emotional subscale of FACT-G, emotional vulnerability subscale of HWS, | IBMS showed a statistically significant reduction in HADS-depression compared to CBT. The effect sizes of the comparison between the two groups were expected to be small. | |||
| Li | HADS-anxiety, HADS-depression | Intervention group exhibited better changes in patient and caregiver quality of life, HADS, and intimacy subscales. | |||
| Kubo | HADS-anxiety, HADS-depression, | No statistically significant differences in change in anxiety, depression, sleep, and fatigue were observed between study arms. | |||
| Mosher | PROMIS-anxiety, | The intervention had no effect on patient pain, caregiver burden, patient and caregiver fatigue, mental health outcomes, or social outcomes. These results also did not change over time. | |||
| Paterson | HADS | No statistically significant changes in anxiety, depression, and health-related QoL scores over time between or within groups. | |||
| McCaughan | SSOSQ | The men in the intervention group were better at communication and support outcomes than the men in the control group. Partners in the study may have benefited the most because they may need intervention more than men. | |||
| Milbury | MDASI-BT affective factor, | DY patients showed clinically significant improvements in overall cancer symptom severity, depression, and psychological QoL. DY caregivers showed clinically significant improvements in depressive symptoms, fatigue, and mental QoL. | |||
| Badr | PROMIS-anxiety, | Patients and spouses in the experimental group demonstrated moderate to large effects relative to depression and cancer-specific distress. | |||
| Porter | IES | No significant differences between CCST and HLI were noted in cancer-related distress for patients. | |||
| Mazanec | PROMIS-anxiety, | At least 40% of patients in the intervention group showed improvement in depression, anxiety, and emotional distress. Caregivers showed little improvement in outcome variables. | |||
| Lambert | HADS-anxiety, HADS-depression, | Both groups reported a decrease in distress, but the experimental group showed a smaller decrease than the control group. | |||
| Hsiao | BDI, | For patients, CSG reduces intimacy anxiety more than ISP. CSG appears to be more effective for partners as it reduces partner anxiety and depression and improves positive mood. | |||
| Dvorak | POMS, | The experimental group showed statistically significant improvements in mood and anxiety. | |||
| Chambers | BSI-18, | For all participants, overall psychological and cancer-specific distress decreased over time, positive adjustment increased, and cancer-specific distress had a moderate to large effect. Only the psychologist-led intervention produced a significant decline in distress for less-educated participants. | |||
| Northouse | BHS, | A significant increase in emotional QoL was reported for control, Extensive, and Brief patients at the 3-month follow-up. However, no significant change was observed for caregivers' emotional QoL at the 3-month and 6-month follow-ups. | |||
| Clark | FACT-G, | There was no difference in mood states between the two groups. | |||
| Ledderer | WHO-5 | The QoL and well-being of patients and their caregivers were improved in the intervention group and the control group, but no significant difference was found between the two groups. | |||
| Manne | MHI-38, | After IET treatment, survivors showed a significant reduction in high-level cancer concerns, while for partners, the IET group improved cancer-specific distress. | |||
| Kayser | Emotional well-being of FACT-B, QL-SP | The mean score of patients' QoL in the PICP arm was higher, but no statistically significant difference. | |||
| Campbell | SF-36 [MCS], | CST partners reported less caregiver strain, depression, fatigue and more vigor; observed effect sizes were close to the level of statistical significance. | |||
| Giesler | CES-D, | The intervention group showed long-term improvements in cancer concerns. | |||
| Northouse | BHS, | Patients with recurrent breast cancer who participated in FOCUS reported significantly lower feelings of hopelessness at the 3-month follow-up than patients in TAU. | |||
| Christensen | PSI, | The anxiety levels of the couples were similar pre- and post-intervention. |
BDI, Beck Depression Inventory; BHS, Beck Hopelessness Scale; BSI, Brief Symptom Inventory; CBM, couple-based meditation intervention; CBT, cognitive behavioral therapy; CES-D, Center for Epidemiological Studies-Depression Measure; CSC, couple-based supportive communication; CSG, couples support group; CQOLC, Caregiver Quality of Life Index–Cancer Scale; CSI, Caregiver Strain Index; DAS, Death Anxiety Scale; FACT-B, Functional Assessment of Cancer Therapy–Breast; FACT-G, Functional Assessment of Cancer Therapy–General; FP, Follow-up; GAD-2, Generalized Anxiety Disorder-2 Scale; HADS, Hospital Anxiety and Depression Scale; HWS, Holistic Well-Being Scale; IES, Impact of Events Scale; MDASI-BT, MD Anderson Symptom Inventory Brain Tumor Module; MHI, Mental Health Inventory; MLQ, Meaning of Life Questionnaire; MUIS, Mishel Uncertainty in Illness Scale; NCCN DT, NCCN Distress Thermometer; NS, not specified; PHQ-2, Two-Question Patient Health Questionnaires; POMS, Profile of Mood States; POMS-SF, Profile of Mood States-Short Form; PROMIS, Patient-Reported Outcomes Measurement Information System; PSI, Psychological Screening Inventory; PTGI, Posttraumatic Growth Inventory; QL-SP, Quality of Life Questionnaire for Spouses; SESCI, Self-Efficacy for Symptom Control Inventory; SF-36 [MCS], Medical Outcomes Study 36-Item Short-Form Survey, Mental Component Summary; SE, supportive-expressive intervention; SSOSQ, 16-Item Symptom Scale of the Omega Screening Questionnaire; STAI-S, State Trait Anxiety Inventory-State Anxiety; TAU, treatment as usual; WHO-5, WHO-Five Well-Being Index.
Fig. 2Forest plots of patient and partner effect sizes and 95% confidence intervals.
Pooled effect size of outcomes for cancer patients and their family caregivers.
| Aspects/outcomes | Pooled effect size SMD (95% | |||
|---|---|---|---|---|
| Pre to post | 8 | 691 | 0.04 (-0.41, 0.48) | 88% |
| Post to follow-up | 3 | 220 | −0.68 (-1.77, −0.41) | 93% |
| Pre to post | 7 | 651 | −0.31 (-0.51, −0.12) | 17% |
| Post to follow-up | 3 | 220 | 0.13 (-0.85, 1.10) | 92% |
| Pre to post | 7 | 758 | −0.32 (-0.46, −0.18) | 0% |
| Post to follow-up | 3 | 498 | −0.13 (-0.60, 0.34) | 84% |
| Pre to post | 7 | 532 | −0.44 (-1.03, 0.15) | 91% |
| Post to follow-up | 3 | 220 | −0.56 (-1.82, 0.69) | 95% |
| Pre to post | 6 | 492 | 0.12 (-0.16, 0.44) | 63% |
| Post to follow-up | 3 | 220 | −0.08 (-0.34, 0.19) | 0% |
| Pre to post | 7 | 758 | 0.02 (-0.23, 0.26) | 52% |
| Post to follow-up | 3 | 498 | −0.36 (-0.84, 0.13) | 76% |
k, number of studies; n, number of patient-caregiver dyads.
Moderator analyses for patient emotional outcomes.
| Outcomes and moderators | Level | Hedges' | Lower limit | Upper limit | ||||
|---|---|---|---|---|---|---|---|---|
| Delivery type | Face-to-face | 6 | −0.21 | 0.46 | −1.11 | 0.69 | −0.45 | 0.65 |
| Telephone | 3 | −0.05 | 0.15 | −0.34 | 0.23 | −0.35 | 0.73 | |
| Interventionist | Psychologist | 5 | −0.16 | 0.11 | −0.37 | 0.05 | −1.48 | 0.14 |
| Therapist | 5 | −0.14 | 0.53 | −1.19 | 0.90 | −0.27 | 0.79 | |
| Frequency intervention (time) | < 6 | 4 | −0.04 | 0.13 | −0.29 | 0.21 | −0.32 | 0.75 |
| ≥ 6 | 7 | −0.21 | 0.33 | −0.86 | 0.45 | −0.62 | 0.54 | |
| Delivery type | Face-to-face | 5 | −0.13 | 0.32 | −0.76 | 0.49 | −0.42 | 0.68 |
| Telephone | 3 | −0.20 | 0.12 | −0.43 | 0.03 | −1.72 | 0.09 | |
| Interventionist | Psychologist | 5 | −0.36 | 0.11 | −0.58 | −0.15 | −3.37 | 0.00∗ |
| Therapist | 4 | 0.18 | 0.28 | −0.36 | 0.73 | 0.66 | 0.51 | |
| Frequency intervention (time) | < 6 | 5 | −0.28 | 0.10 | −0.49 | −0.08 | −2.68 | 0.00∗ |
| ≥ 6 | 5 | −0.04 | 0.27 | −0.58 | 0.50 | −0.15 | 0.88 | |
| Session duration (hr) | < 6 | 7 | −0.29 | 0.08 | −0.45 | −0.13 | −3.52 | 0.00∗∗ |
| ≥ 6 | 3 | 0.17 | 0.49 | −0.84 | 1.09 | 0.26 | 0.08 | |
| Delivery type | Face-to-face | 3 | −0.42 | 0.21 | −0.84 | −0.01 | −2.02 | 0.04∗ |
| Online | 3 | −0.19 | 0.13 | −0.45 | 0.07 | −1.41 | 0.16 | |
| Telephone | 4 | −0.18 | 0.21 | −0.58 | 0.22 | −0.89 | 0.38 | |
| Interventionist | Psychologist | 3 | −0.31 | 0.12 | −0.55 | −0.07 | −2.51 | 0.01∗ |
| Therapist | 5 | −0.22 | 0.13 | −0.47 | 0.02 | −1.77 | 0.08 | |
| Frequency intervention (time) | < 7 | 6 | −0.15 | 0.06 | −0.27 | −0.03 | −2.39 | 0.02∗ |
| ≥ 7 | 4 | −0.23 | 0.14 | −0.49 | 0.04 | −1.69 | 0.09 | |
| Session duration (hr) | < 7 | 5 | −0.23 | 0.10 | −0.43 | −0.04 | −2.40 | 0.01∗ |
| ≥ 7 | 5 | −0.13 | 0.07 | −0.27 | 0.01 | −1.82 | 0.07 | |
SE, standard error; ∗P < 0.05; ∗∗P < 0.001.
Fig. 3Risk of bias summary.
Fig. 4Filled funnel plot of depression, anxiety, and cancer-related distress after using trim-and-fill method.